It’s hard to believe that multiple governments, including the United Nations still regard cannabis as an illegal drug. Despite the fact that it has a wide range of therapeutic properties, it still faces a heavy opposition, especially in North America. Granted, we might not know for sure with absolute mainstream scientific certainty that cannabis oil, without a shadow of any doubt, kills all cancers in all humans with cancer. We don’t know this, and can’t say it for sure because there hasn’t been any (unfortunately) human clinical trials to see if it’s actually true.
The Science Behind The Claims
What we do know, on the other hand, is that multiple studies in peer reviewed scientific journals have clearly outlined the antitumoral effects of cannabis. For example, a study published in the British Journal of Cancer, conducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumor growth. They were responsible for the first clinical study aimed at assessing cannabinoid antitumoral action. Cannabinoid delivery was safe and was achieved with zero psychoactive effects. THC was found to decrease tumor cells in two out of the nine patients. (1)
A study published in the Journal of Pharmacology and Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess anti-tumor properties. The study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour. The study concluded that cannabidiol was able to produce significant antitumor activity.
A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis. The study provides strong evdience for the use of cannabinoid based therapies for the management of breast cancer.
A study published in the American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.
A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.
A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient. Overall, data indicated that cannabinoids decrease cancer cell invasiveness.
The list literally goes on and on, the truth is that there are hundreds of peer reviewed studies showing that the active constituents within cannabis play a significant role in killing cancer cells. Again, there are hundreds of these studies, and the anti-tumoral effects of it when it comes to cancer have been known for decades. So ask yourself, if all of this has been known for such a long time, why have we not seen any human clinical trials take place?
Human Success Stories
Regardless of the lack of clinical trials regarding cannabis as a treatment, it has not stopped individuals with cancer taking this route as a form of alternative cancer treatment.
Human success stories are similar to the science behind the claims, there are many of them.
One of the best publicly known examples is Mykayla Comstock. You can check out her website here . In Mykala’s case, her cell counts affected by cannabis decreased as soon as she began cannabis treatment, from a 51 % lymphoblast count in July of 2012 all the way to 0 % in August of 2012. July 30th was the very last time they found lymphoblasts in Mykayla’s blood smear.
A case study we wrote about examines a teenage female who was diagnosed with acute lymphoblastic leukemia with a Philadelphia chromosome mutation. This mutation accounts for a much more aggressive case of Leukemia.The patient underwent standard treatments of acute and aggressive chemotherapy as well as bone marrow transplants. It was found that none of these treatments were effective which led the family to explore alternatives. The alternative they chose was to treat with cannabinoids administered orally in the form of hemp oil.
In a recent report, the National Cancer Institute (NCI), part of the Federal government’s National Institutes of Health (NIH), stated that marijuana “inhibited the survival of both estrogen receptor–positive and estrogen receptor–negative breast cancer cell lines.” The same report showed marijuana slows or stops the growth of certain lung cancer cells and suggested that marijuana may provide “risk reduction and treatment of colorectal cancer.”
Watch this Video: